Informação sobre produto
- <span class="text-smallcaps">L</smallcap>-Leucinamide, N-acetyl-<smallcap>L</span>-leucyl-N-(1-formylpentyl)-, (S)-
- <span class="text-smallcaps">L</smallcap>-Leucinamide, N-acetyl-<smallcap>L</span>-leucyl-N-[(1S)-1-formylpentyl]-
- ALLNal
- ALLnL
- CI-1 (peptide)
- Calp I
- Calpain inhibitor I
- Mg 101
- N-Ac-Leu-Leu-Norleucinal
- N-Acetyl-<span class="text-smallcaps">L</smallcap>-leucinyl-<smallcap>L</smallcap>-leucinyl-<smallcap>L</span>-norleucinal
- Ver mais sinónimos
- N-Acetyl-<span class="text-smallcaps">L</smallcap>-leucyl-N-[(1S)-1-formylpentyl]-<smallcap>L</span>-leucinamide
- N-Acetyl-L-Leucyl-L-Leucyl-L-Norleucinal
- N-Acetyl-Leu-Leu-Nle-Cho
- N-Acetyl-Leu-Leu-Norleucinal
- N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide
- N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]leucinamide
- N-acetylleucyl-N-(1-oxohexan-2-yl)leucinamide
- L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-
- L-Leucinamide, N-acetyl-L-leucyl-N-(1-formylpentyl)-, (S)-
- N-Acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide
Ac-Leu-Leu-Nle-H (Aldehyde) is a Toll-like receptor ligand that is active against bowel disease. Aldehyde has been shown to have chemotherapeutic effects in vitro and in vivo, even at low doses. It also inhibits the growth of certain cancer cells by inducing apoptosis, which may be due to its ability to activate the nuclear factor kappa B/Toll-like receptor pathway. This agent has been shown to bind to DNA, inhibit transcription, and induce programmed cell death. Aldehyde also binds to proteins that are involved in protein synthesis and cell division. These properties make it useful for the treatment of infectious diseases and cancer.
Propriedades químicas
Consulta técnica sobre: 3D-IAL-3671-PI Ac-Leu-Leu-Nle-H (Aldehyde)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.